A finger prick. A drop of blood. Repeat several times a day, for life.
For the millions who live with diabetes, each day is marked by small rituals of pain — the finger prick, the test strip, the reading, repeated without end. Now, rumors surrounding the Apple Watch 7 suggest that technology may be approaching a threshold where that burden could be lifted, replaced by a sensor worn on the wrist that reads blood sugar continuously, without ever breaking the skin. Whether through terahertz spectroscopy or some adjacent innovation, Apple appears to be pursuing a vision in which the boundary between consumer device and medical instrument quietly dissolves. The promise is not yet a product, but the direction of travel is unmistakable.
- Millions of people with diabetes endure multiple finger pricks daily — a relentless, lifelong routine that carries infection risk and quietly erodes quality of life.
- Rumors and patent filings suggest Apple Watch 7 may include a non-invasive glucose sensor using terahertz spectroscopy, a technology that reads blood sugar through the skin without drawing blood.
- Samsung is pursuing similar ground with the Galaxy Watch 4, signaling that the race to solve non-invasive glucose monitoring has become a genuine industry-wide contest with enormous stakes.
- Apple's wrist-based sensors have historically traded clinical precision for accessibility — a glucose sensor would likely follow suit, useful for trend alerts but not yet a replacement for traditional meters in dosing decisions.
- Even an imperfect continuous sensor could be transformative, catching dangerous highs and lows before they become crises and reducing the friction that leads people to skip checks altogether.
For people living with diabetes, the day is structured around small, necessary pain — a finger prick, a test strip, a reading, repeated several times before nightfall. Apple's next Watch may be preparing to interrupt that rhythm.
Rumors suggest the Apple Watch 7 will include a blood glucose sensor capable of monitoring sugar levels continuously, without ever piercing the skin. Patent filings uncovered by AppleInsider point toward terahertz spectroscopy — a method that emits electromagnetic waves through skin and measures what reflects back from the tissue beneath. The radiation is non-ionizing, posing no cellular damage, and the patents, while never explicitly naming glucose or the Watch, describe a system that could theoretically be adapted for exactly that purpose.
Apple has been building toward this kind of capability for years. The Series 4 brought EKG functionality. The Series 6 added pulse oximetry. Each addition has been incremental but cumulative, and the Watch has since been credited with detecting arrhythmias, flagging falls, and even surfacing COVID-19 infections before symptoms appeared. A glucose sensor would be the next step in a long, deliberate march.
Samsung is pursuing similar territory with the Galaxy Watch 4, reportedly exploring Raman spectroscopy in collaboration with MIT. The market is vast, the need genuine, and the competition real.
The honest caveat is precision. Apple's health sensors have never matched dedicated medical devices, and a glucose sensor would likely follow the same pattern — valuable for trend detection and early alerts, but not reliable enough to replace a traditional meter when insulin dosing is on the line. Verification would still be necessary.
And yet, even that partial solution could matter enormously. Continuous visibility into glucose trends, alerts before levels become dangerous, reduced friction around daily monitoring — these things could change the texture of life with diabetes in ways that go beyond convenience. The Watch would shift from luxury object to something closer to essential equipment.
Patent filings are often dead ends. But if this one becomes a product, it would mark the moment a wearable earns its place not as a gadget, but as a genuine instrument of care.
For millions of people with diabetes, the daily routine is punctuated by small, necessary pain. A finger prick. A drop of blood on a test strip. A reading. Repeat several times a day, every day, for life. It's the price of staying alive. But Apple's next generation of wearables may be about to change that equation.
Rumors have circulated that the Apple Watch 7 will include a blood glucose sensor capable of monitoring blood sugar levels continuously, without ever breaking the skin. If true, it would represent a genuine departure from the needle-and-strip method that has defined diabetes management for decades. The technology would work passively, reading glucose levels throughout the day and alerting wearers to dangerous highs and lows before they become emergencies.
Apple has been steadily expanding the Watch's medical capabilities for years. The Series 4 added electrocardiogram functionality. The Series 6 introduced a pulse oximeter, a feature that proved especially relevant during the pandemic when measuring blood oxygen became suddenly urgent. Each addition has been modest in isolation but cumulative in impact—the Watch has been credited with detecting irregular heartbeats, alerting wearers to falls, and even flagging COVID-19 infections days before symptoms appeared. A glucose sensor would fit naturally into this trajectory, another sensor added to the growing array of health monitors on the wrist.
The technical approach Apple appears to be pursuing, based on patent filings uncovered by AppleInsider, involves terahertz spectroscopy. The patents describe a system that would emit electromagnetic waves in the terahertz frequency range through the skin, then measure the light reflected back from the tissue beneath. The terahertz radiation is non-ionizing—it doesn't damage cells the way X-rays do—and any effect on tissue would be thermal, similar to the warmth from radio frequency emissions. The patents don't explicitly mention glucose or the Apple Watch, but the underlying principle could theoretically be adapted to measure blood sugar levels through the skin.
Apple is not alone in pursuing this approach. Samsung has been working on similar technology, reportedly exploring Raman spectroscopy for the Galaxy Watch 4, with research collaboration from MIT. The race to solve non-invasive glucose monitoring has attracted attention from multiple companies because the market is enormous and the need is genuine. Millions of people worldwide live with diabetes. The daily finger pricks are not merely inconvenient—they represent a genuine burden on quality of life, a constant reminder of illness, a source of infection risk, and a barrier to consistent monitoring.
There are important caveats. Apple's Watch sensors have never matched the precision of dedicated medical devices. An EKG on the wrist is useful for detecting certain arrhythmias but is not a replacement for a clinical electrocardiogram. A pulse oximeter on the Watch is helpful for general awareness but less accurate than a hospital-grade device. A glucose sensor would likely follow the same pattern—valuable for trend detection and alert functions, but not necessarily precise enough to replace traditional blood glucose meters for critical dosing decisions. A person with diabetes would still need to verify readings with a traditional test before adjusting insulin.
But even that limitation would represent a meaningful improvement. The ability to see glucose trends continuously throughout the day, to receive alerts when levels are climbing dangerously high or dropping too low, to make informed decisions about meals and activity and medication timing—these things could be genuinely life-changing. The Watch could catch problems before they become crises. It could reduce the friction that sometimes causes people to skip glucose checks, which in turn leads to poor control and long-term complications.
As with all Apple patents, there is no certainty this technology will ever reach a consumer product. Patent filings are often exploratory, dead ends that never become real. But if Apple does bring a glucose sensor to the Watch, it would be the kind of feature that justifies the device's existence for an entire category of users. It would be the moment a luxury gadget becomes something closer to essential medical equipment.
Citas Notables
Having the Apple Watch provide continuous blood sugar readings could be life-saving, allowing detection of dangerous glucose peaks and enabling timely intervention— Analysis of potential clinical impact
La Conversación del Hearth Otra perspectiva de la historia
Why does this matter so much to people with diabetes? Isn't glucose monitoring already solved?
It's solved, but the solution is painful and intrusive. Imagine checking your blood sugar five times a day for fifty years. That's a lot of finger pricks, a lot of small wounds, a lot of friction in your life. Continuous monitoring without needles would change that completely.
But the patents don't even mention glucose. How confident should we be that this is actually about blood sugar?
That's fair skepticism. The patents describe a general spectroscopy system. Apple could use it for many things. But the timing—rumors of a glucose sensor, Samsung working on the same problem, the medical focus of the Watch—it all points in one direction. It's not certain, but it's plausible.
If Apple does this, will it be as accurate as a traditional glucose meter?
Almost certainly not. The Watch sensors are always a step behind dedicated medical devices. But accuracy isn't the only thing that matters. If it catches dangerous highs and lows and lets you see trends, that's valuable even if you still need to verify with a traditional test sometimes.
What's the real barrier to making this work?
Measuring glucose through skin without drawing blood is genuinely hard. Light has to pass through layers of tissue and come back with useful information. Terahertz waves might do it, but there's a reason this hasn't been solved yet. It's not simple engineering—it's fundamental physics.
So we might never see this on a Watch?
Right. This could be a dead-end patent, something Apple explored and abandoned. But if they crack it, even imperfectly, millions of people would want it.